Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine and IPL for Dry Eye in Contact Lens Wearers
NCT06392438Phase 3Recruiting
- Sponsor
- Université de Sherbrooke
- Start
- Apr 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cyclosporine 2% ophthalmic solution in dry eye disease (DED) (2 arms), sponsored by Université de Sherbrooke. Primary endpoint: Contact Lens Dry Eye Questionnaire-8 (f-CLDEQ-8) Score at Week 16. Started Apr 2024; status: recruiting.
02
Drugs
cyclosporine 2% ophthalmic solution
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06392438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06392438.